Development and validation of a nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North West Ethiopia: An application of prediction modelling.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 05 02 2022
accepted: 12 07 2022
entrez: 10 8 2022
pubmed: 11 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

Multi-drug resistant tuberculosis has impeded tuberculosis prevention and control due to its low treatment efficiency and prolonged infectious periods. Early culture conversion status has long been used as a predictor of good treatment outcomes and an important infection control metric, as culture-negative patients are less likely to spread tuberculosis. There is also evidence that suggests that delayed sputum conversion is linked to negative outcomes. Therefore, this study was aimed at developing a nomogram to predict the risk of late culture conversion in patients with multi-drug resistant tuberculosis using readily available predictors. The objective of this study was to develop and validate a risk prediction nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North-West Ethiopia. Multi-drug resistant tuberculosis data from the University of Gondar and the Debre Markos referral hospitals have been used and a total of 316 patients were involved. The analysis was carried out using STATA version 16 and R version 4.0.5 statistical software. Based on the binomial logistic regression model, a validated simplified risk prediction model (nomogram) was built, and its performance was evaluated by assessing its discriminatory power and calibration. Finally, decision curve analysis (DCA) was used to assess the generated model's clinical and public health impact. Registration group, HIV co-infection, baseline BMI, baseline sputum smear grade, and radiological abnormalities were prognostic determinants used in the construction of the nomogram. The model has a discriminating power of 0.725 (95% CI: 0.669, 0.781) and a P-value of 0.665 in the calibration test. It was internally validated using the bootstrapping method, and it was found to perform similarly to the model developed on the entire dataset. The decision curve analysis revealed that the model has better clinical and public health impact than other strategies specified. The developed nomogram, which has a satisfactory level of accuracy and good calibration, can be utilized to predict late culture conversion in MDR-TB patients. The model has been found to be useful in clinical practice and is clinically interpretable.

Identifiants

pubmed: 35947625
doi: 10.1371/journal.pone.0272877
pii: PONE-D-22-02882
pmc: PMC9365138
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0272877

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Tuberc Lung Dis. 2013 Apr;17(4):520-5
pubmed: 23485386
Rev Saude Publica. 2019 Sep 23;53:77
pubmed: 31553380
PLoS One. 2018 Jun 21;13(6):e0199320
pubmed: 29927980
JAMA Surg. 2021 Jul 1;156(7):675-676
pubmed: 33825807
BMC Infect Dis. 2017 Apr 24;17(1):299
pubmed: 28438118
Ann Transl Med. 2019 Dec;7(23):796
pubmed: 32042812
Int J Tuberc Lung Dis. 2016 Dec;20(12):1671-1676
pubmed: 27931345
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
Lancet Respir Med. 2015 Mar;3(3):201-9
pubmed: 25726085
PLoS One. 2018 Jun 26;13(6):e0198080
pubmed: 29944658
Int J Tuberc Lung Dis. 2012 Jun;16(6):724-32
pubmed: 22613684
PLoS One. 2014 Apr 15;9(4):e94890
pubmed: 24736471
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):148-50
pubmed: 26884490
PLoS One. 2011 Jan 06;6(1):e15841
pubmed: 21253585
PLoS One. 2018 Oct 3;13(10):e0204982
pubmed: 30281679
Int J Tuberc Lung Dis. 2011 Nov;15(11):1556-9, i
pubmed: 22008773
Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1060-1067
pubmed: 31627770
BMC Infect Dis. 2018 Mar 6;18(1):114
pubmed: 29510666
Infect Drug Resist. 2020 Jul 27;13:2547-2556
pubmed: 32821129
J Infect. 2018 Nov;77(5):357-367
pubmed: 30036607
Int J Tuberc Lung Dis. 2001 Apr;5(4):321-8
pubmed: 11334250
Infect Drug Resist. 2021 Apr 28;14:1659-1667
pubmed: 33953577
Epidemiol Infect. 2017 Oct;145(14):3020-3034
pubmed: 28903800
Eur Respir J. 2016 Oct;48(4):1160-1170
pubmed: 27587552
Eur Respir J. 2017 Mar 22;49(3):
pubmed: 28331033
Int J Tuberc Lung Dis. 2014 May;18(5):564-70
pubmed: 24903794
Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43
pubmed: 23107633
PLoS One. 2014 Apr 04;9(4):e93206
pubmed: 24705411

Auteurs

Denekew Tenaw Anley (DT)

Department of Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Temesgen Yihunie Akalu (TY)

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Mehari Woldemariam Merid (MW)

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Anteneh Mengist Dessie (AM)

Department of Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Melkamu Aderajew Zemene (MA)

Department of Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Biruk Demissie (B)

Department of Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Getachew Arage (G)

Department of Pediatrics and Child Health Nursing, Debre Tabor University, Debre Tabor, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH